Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.68 |
| ▸ | MAOA | P21397 | 16/20 | 0.66 |
| ▸ | MAOB | P27338 | 16/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | PRKCI | P41743 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31711410 | 0.91 | HSD17B10 (0.62) | ALOX15TSHRHSD17B10MAOAMAOB | |
| SCHEMBL7389120 | 0.91 | HSD17B10 (0.62) | ALOX15TSHRHSD17B10MAOAMAOB | |
| SCHEMBL7527304 | 0.90 | HSD17B10 (0.66) | ALOX15TSHRHSD17B10MAOAMAOB | |
| SCHEMBL7399814 | 0.86 | MAOB (0.57) | ALOX15TSHRHSD17B10MAOAMAOB | |
| SCHEMBL21052066 | 0.86 | MAOB (0.67) | MAOAMAOB | |
| SCHEMBL2729878 | 0.84 | TSHR (0.93) | ALOX15TSHRHSD17B10MAPTL3MBTL1 | |
| SCHEMBL20807156 | 0.84 | MAOA (0.58) | HSD17B10MAOAMAOB | |
| SCHEMBL21098679 | 0.83 | MAOB (0.63) | ALOX15TSHRHSD17B10MAOAMAOB | |
| SCHEMBL21052060 | 0.83 | MAOB (0.60) | MAOAMAOB | |
| SCHEMBL21052051 | 0.83 | MAOB (0.60) | MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200299306-A1 | COMPOUNDS WITH A BENZO[A]CARBAZOLE STRUCTURE AND USE THEREOF | UNIVERSITA' DI PISA (IT) | 2020-09-24 | — | — | US | disclosed |
| US-6417213-B2 | ANTICOAGULANTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-07-09 | — | — | US | disclosed |
| US-20020006944-A1 | Tricyclic compounds, their production and use | OHKAWA SHIGENORI (JP) | 2002-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020006944-A1 | Tricyclic compounds, their production and use | CNR1, PTGER1, PTGDR | ALOX15 448/4885TSHR 179/4885HSD17B10 864/4885 |
| US-20200299306-A1 | COMPOUNDS WITH A BENZO[A]CARBAZOLE STRUCTURE AND USE THEREOF | MKI67, CCNI, CASP3 | ALOX15 539/4885TSHR 2723/4885HSD17B10 738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.